impact factor, citescore
logo
 

Letters to the Editor

 

Successful therapy of refractory dermatomyositis skin rash with anifrolumab


1, 2, 3, 4

 

  1. Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. claudio.galluzzo@ausl.re.it
  2. Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  3. Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  4. Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, and University of Modena and Reggio Emilia, Modena, Italy.

CER18791
2026 Vol.44, N°2
PI 0408, PF 0409
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 40737057 [PubMed]

Received: 02/04/2025
Accepted : 05/05/2025
In Press: 29/07/2025
Published: 24/02/2026

Rheumatology Article